Global Core Molecular Laboratory Market Analysis and Forecast 2019-2028
$2,800.00 – $5,440.00
Technological advancements and the adoption of personalized treatment to augment to grow the market revenue
The global core molecular laboratory market is expected to witness a robust growth rate of around 10.2% and was valued at US$ 7.5 Billion in 2021. According to RationalStat Analysis, the growth of the global core molecular laboratory market is affected by the factors such as the increasing demand for molecular diagnostics and the growing adoption of next-generation sequencing (NGS) technologies.
Moreover, these services are essential for a wide range of applications, including biomedical research, drug discovery and development, clinical diagnostics, and personalized medicine which is expected to play a major role in driving the revenue for the global core molecular laboratory market.
In addition, the growth of the global core molecular laboratory market is being driven by several factors, including advances in technology, the increasing demand for molecular testing services, and the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease. Additionally, the growing adoption of precision medicine and personalized treatment approaches is also contributing to the expansion of this market.
Favorable government policies, increasing demand for personalized medicine, and the growing prevalence of chronic diseases are anticipated to fuel the market growth
The rising incidence of chronic diseases such as cancer, cardiovascular diseases, and diabetes is driving the demand for molecular diagnostics and personalized medicine. Core molecular laboratories play a critical role in providing advanced molecular testing services to aid in disease diagnosis, prognosis, and treatment.
Moreover, the development of advanced sequencing technologies, such as next-generation sequencing (NGS), and the increasing availability of high-throughput screening technologies are driving the growth of the core molecular laboratories market. These technologies enable faster and more accurate molecular testing and analysis, thus improving patient outcomes.
In addition, the increasing focus on personalized medicine and precision medicine is driving the growth of the core molecular laboratories market. Molecular testing services are critical in identifying the genetic markers that can guide personalized treatment and improve patient outcomes.
Furthermore, governments across the globe and healthcare organizations are investing heavily in healthcare infrastructure, which is driving the growth of the core molecular laboratories market. The increasing healthcare expenditure is enabling the expansion of core molecular laboratory facilities and the development of new molecular testing services.
North America held the dominant market share in the global core molecular laboratories market
North America is currently the largest market for core molecular laboratory services, followed by Europe and Asia-Pacific. However, the Asia-Pacific region is expected to experience the highest growth rate during the forecast period, due to the increasing investment in healthcare infrastructure and the rising demand for advanced diagnostic services in countries such as China and India.
North America is currently the largest market for core molecular laboratory services, primarily due to the well-established healthcare infrastructure, high healthcare expenditure, and increasing prevalence of chronic diseases in the region. The United States is the major contributor to the North American core molecular laboratory market, and the country’s dominance can be attributed to the presence of major players in the region, technological advancements, and favorable government policies.
Whereas, the European region is the second-largest market for core molecular laboratory services, with Germany, France, and the UK being the major contributors. The region’s market growth is driven by the increasing prevalence of chronic diseases, rising demand for personalized medicine, and growing government support for precision medicine and genomics research.
In addition, the Asia-Pacific region is expected to experience the highest growth rate during the forecast period, due to the increasing investment in healthcare infrastructure and the rising demand for advanced diagnostic services in countries such as China, India, Japan, and South Korea. Moreover, the region is witnessing a surge in the number of collaborations between research institutes and biotech companies to develop innovative products and technologies.
Furthermore, Latin America, and the Middle East & Africa are also expected to witness significant growth in the core molecular laboratory market during the forecast period, driven by increasing healthcare expenditure, growing awareness about the benefits of molecular diagnostics, and rising government initiatives to improve healthcare infrastructure.
Overall, the global core molecular laboratory market is expected to experience significant growth across all regions due to the increasing demand for advanced molecular testing services, the growing adoption of precision medicine, and technological advancements in the field of genomics and molecular diagnostics.
Market Structure and Competitive Landscape
The global core molecular laboratory market is fragmented in nature with various players operating in the market, some of the prominent players that contribute significantly to the global core molecular laboratory market include Thermo Fisher Scientific, Illumina Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Agilent Technologies Inc., and F. Hoffmann-La Roche AG, among others.
These companies are investing heavily in research and development to advance their technologies and expand their product portfolios to meet the growing demand for molecular testing services. Moreover, the companies are focusing on strategic partnerships, acquisitions, and product development to expand their market presence and meet the growing demand for core molecular laboratory products and services.
- In January 2022, PathGroup, one of the largest providers of anatomic pathology, digital pathology, clinical and molecular laboratory services in the United States, announced the acquisition of Pathology Consultants, a leading provider of pathology services based in Greenville, S.C. Together, PathGroup and Pathology Consultants will provide physicians and patients across the Southeast with superior quality and service levels for their comprehensive testing needs.
- In April 2017, Siemens Healthcare and Thermo Fisher Scientific today announced a new strategic relationship that includes the integration of Thermo Fisher Scientific’s real-time PCR system into Siemens’ VERSANT® kPCR Molecular Solution. The combined workflow will offer laboratories Siemens complete molecular testing.
Key Market Segmentation
RationalStat has segmented the global core molecular laboratory market based on product, technology, application, and region.
- By Product
- Test Kits
- Services
- By Technology
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization (ISH)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Chips and Microarrays
- Mass Spectrometry
- Sequencing
- Transcription Mediated Amplification (TMA)
- By Application
- Oncology
- Breast Cancer
- Kidney Cancer
- Prostate Cancer
- Colorectal Cancer
- Blood Cancer
- Lung cancer
- Liver Cancer
- Pharmacogenomics
- Infectious Diseases
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Clostridium difficile
- Vancomycin-Resistant Enterococci (VRE)
- Carbapenem-resistant bacteria
- Flu
- Respiratory Syncytial Virus (RSV)
- Candida
- Tuberculosis (TB) and drug-resistant TB
- Meningitis
- Gastrointestinal panel testing
- Chlamydia
- Gonorrhea
- HIV
- Hepatitis C
- Hepatitis B
- Genetic Testing
- Newborn screening
- Predictive and Presymptomatic Testing
- Neurological Diseases
- Cardiovascular Diseases
- Microbiology
- Hematology
- Oncology
- By Region
- North America
- US
- Canada
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Western Europe
- Germany
- UK
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- Rest of Eastern Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- ASEAN (Indonesia, Vietnam, Malaysia, etc.)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- South Africa
- Turkey
- Rest of the Middle East & Africa
- North America
Research Methodology
RationalStat has developed a state-of-the-art research methodology to crunch numbers and provide the best possible real-time insights to clients. We combine a varied range of industry experience, data analytics, and experts’ viewpoint to create a research methodology for market sizing and forecasting.
RationalStat combines a mix of secondary sources as well as primary research to assess the market size and develop a forecast. Key steps involved in accurately deriving the market numbers are:
- Defining the problem by understanding the type of market and data required by the client.
- Data gathering and collection through relevant paid databases, publicly available sources, company reports, annual reports, surveys, and interviews.
- Formulating a hypothesis to create market numbers, forecast, influencing factors, and their relevance.
- Evaluating and analyzing the data by referring to data sources utilized and leveraged.
- Validating, interpreting, and finalizing the data by combining the details gathered from primary and secondary sources with the help of experienced analysts.
Secondary Sources
- Annual reports, company filings, investor presentations, product catalogs, and company documents
- Industry and market-related documents available in the public domain
- Paid database including Bloomberg, Factiva, S&P Capital IQ, FactSet, Refinitiv Eikon, ICIS, EUWID, and Thomson Reuters, among others
- Whitepapers, research papers, and industry blogs.
Why Buy this Report?
The report is intended for global core molecular laboratory market players, healthcare industry, government organizations, educational organizations, regulatory agencies, and market research firms, among others. The report provides an in-depth analysis of market size, consumption patterns, ongoing market trends and challenges, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights to clients to find the right answers to their business questions.
Frequently Asked Questions (FAQs)
The global core molecular laboratory market is expected to grow at a CAGR of 10.2% during the forecast period 2022-2028.
The global market for the core molecular laboratory was US$ 7.5 Billion in 2022.
Increasing healthcare spending and government support are some of the major trends in the global core molecular laboratory market.
North America is the leading region in this market.
Major companies operating in the global Core Molecular Laboratory market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, etc.
| REGION | Global |
|---|---|
| RELEASE YEAR | 2023 |
| RESEARCH CODE | RST-SAR-129 |
| ADDITIONAL FEATURE | 24×7 Post sales support and 15% free customization |
| User License | Single User/Team License, Corporate License |
Table of Contents
1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.2. Forecasting Factors
6.3. Supply Chain & Value Chain Analysis
6.3.1.Diagnostics Equipment Manufacturers & Suppliers
6.3.2.Reagents Manufacturers
6.3.3.Physicians
6.3.4.Hospitals and Medical Center
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter’s Five Forces Analysis
7. Government Laws and Industry Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Laboratory Equipment Production Overview
10. Market Spending and Use Case Analysis
10.1. By Leading Players
10.2. By Leading Hospitals / Institutions
10.3. By Region
11. Global Core Molecular Laboratory Market: Technology Assessment
Robust assessment of key technologies incorporated in various types of Molecular Diagnostic services that are commercialized in the marketplace
12. Investment Analysis
12.1. Mergers & Acquisitions
12.2. Key Investment Analysis
Robust assessment of major investments made by various industry players along with key application areas, technological assessment, and key applications
13. Parent Market Overview
13.1. Global Healthcare Market
13.2. Global Diagnosis Market
14. Segmental Analysis
14.1. Global Core Molecular Laboratory Market by Product in terms of Value (US$) and Volume (‘000 Units)
14.1.1. Segment Overview
14.1.1.1. Test Kits
14.1.1.2. Services
14.2. Global Core Molecular Laboratory Market by Technology in terms of Value (US$) and Volume (‘000 Units)
14.2.1. Segment Overview
14.2.1.1. Polymerase Chain Reaction (PCR)
14.2.1.1.1. Multiplex PCR
14.2.1.1.2. Other PCR
14.2.1.2. In Situ Hybridization (ISH)
14.2.1.2.1. Instruments
14.2.1.2.2. Reagents
14.2.1.3. INAAT
14.2.1.3.1. Instruments
14.2.1.3.2. Reagents
14.2.1.3.3. Others
14.2.1.4. Chips and Microarrays
14.2.1.4.1. Instruments
14.2.1.4.1.1. Reagents
14.2.1.4.1.2. Others
14.2.1.5. Mass Spectrometry
14.2.1.5.1. Instruments
14.2.1.5.2. Reagents
14.2.1.6. Sequencing
14.2.1.6.1. Instruments
14.2.1.6.2. Reagents
14.2.1.7. Transcription Mediated Amplification (TMA)
14.2.1.7.1. Instruments
14.2.1.7.2. Reagents
14.3. Global Core Molecular Laboratory Market by Application in terms of Value (US$) and Volume (‘000 Units)
14.3.1. Segment Overview
14.3.1.1. Oncology
14.3.1.1.1. Breast Cancer
14.3.1.1.2. Kidney Cancer
14.3.1.1.3. Prostate Cancer
14.3.1.1.4. Colorectal Cancer
14.3.1.1.5. Blood Cancer
14.3.1.1.6. Lung cancer
14.3.1.1.7. Liver Cancer
14.3.1.2. Pharmacogenomics
14.3.1.3. Infectious Diseases
14.3.1.3.1. Methicillin-resistant Staphylococcus Aureus (MRSA)
14.3.1.3.2. Clostridium difficile
14.3.1.3.3. Vancomycin-Resistant Enterococci (VRE)
14.3.1.3.4. Carbapenem-resistant bacteria
14.3.1.3.5. Flu
14.3.1.3.6. Respiratory Syncytial Virus (RSV)
14.3.1.3.7. Candida
14.3.1.3.8. Tuberculosis (TB) and drug-resistant TB
14.3.1.3.9. Meningitis
14.3.1.3.10. Gastrointestinal panel testing
14.3.1.3.11. Chlamydia
14.3.1.3.12. Gonorrhea
14.3.1.3.13. HIV
14.3.1.3.14. Hepatitis C
14.3.1.3.15. Hepatitis B
14.3.1.3.16. Other infectious disease market
14.3.1.4. Genetic Testing
14.3.1.4.1. Newborn screening
14.3.1.4.2. Predictive and Presymptomatic Testing
14.3.1.4.3. Other genetic testing
14.3.1.5. Neurological Diseases
14.3.1.6. Cardiovascular Diseases
14.3.1.7. Microbiology
14.3.1.8. Hematology
14.4. Global Core Molecular Laboratory Market by Region in terms of Value (US$) and Volume (‘000 Units)
14.4.1. North America
14.4.2. Latin America
14.4.3. Western Europe
14.4.4. Eastern Europe
14.4.5. Asia Pacific
14.4.6. Middle East & Africa
15. Regional Analysis
15.1. North America Core Molecular Laboratory Market Analysis and Forecast 2019-2028
15.1.1. Regional Market Overview and Key Takeaways
15.1.2. North America Core Molecular Laboratory Market by Product
15.1.3. North America Core Molecular Laboratory Market by Technology
15.1.4. North America Core Molecular Laboratory Market by Application
15.1.5. North America Core Molecular Laboratory Market by Country
15.1.5.1. US
15.2. Latin America Core Molecular Laboratory Market Analysis and Forecast 2019-2028
15.2.1. Regional Market Overview and Key Takeaways
15.2.2. Latin America Core Molecular Laboratory Market by Product
15.2.3. Latin America Core Molecular Laboratory Market by Technology
15.2.4. Latin America Core Molecular Laboratory Market by Application
15.2.5. Latin America Core Molecular Laboratory Market by Country
15.2.5.1. Brazil
15.2.5.2. Mexico
15.2.5.3. Rest of Latin America
15.3. Western Europe Core Molecular Laboratory Market Analysis and Forecast 2019-2028
15.3.1. Regional Market Overview and Key Takeaways
15.3.2. Western Europe Core Molecular Laboratory Market by Product
15.3.3. Western Europe Core Molecular Laboratory Market by Technology
15.3.4. Western Europe Core Molecular Laboratory Market by Application
15.3.5. Western Europe Core Molecular Laboratory Market by Country
15.3.5.1. Germany
15.3.5.2. UK
15.3.5.3. France
15.3.5.4. Spain
15.3.5.5. Italy
15.3.5.6. Benelux
15.3.5.7. Nordic
15.3.5.8. Rest of Western Europe
15.4. Eastern Europe Core Molecular Laboratory Market Analysis and Forecast 2019-2028
15.4.1. Regional Market Overview and Key Takeaways
15.4.2. Eastern Europe Core Molecular Laboratory Market by Product
15.4.3. Eastern Europe Core Molecular Laboratory Market by Technology
15.4.4. Eastern Europe Core Molecular Laboratory Market by Application
15.4.5. Eastern Europe Core Molecular Laboratory Market by Country
15.4.5.1. Russia
15.4.5.2. Poland
15.4.5.3. Rest of Eastern Europe
15.5. Asia Pacific Core Molecular Laboratory Market Analysis and Forecast 2019-2028
15.5.1. Regional Market Overview and Key Takeaways
15.5.2. Asia Pacific Core Molecular Laboratory Market by Product
15.5.3. Asia Pacific Core Molecular Laboratory Market by Technology
15.5.4. Asia Pacific Core Molecular Laboratory Market by Application
15.5.5. Asia Pacific Core Molecular Laboratory Market by Country
15.5.5.1. China
15.5.5.2. Japan
15.5.5.3. India
15.5.5.4. South Korea
15.5.5.5. Australia
15.5.5.6. ASEAN
15.5.5.7. Rest of Asia-Pacific
15.6. Middle East & Africa Core Molecular Laboratory Market Analysis and Forecast 2019-2028
15.6.1. Regional Market Overview and Key Takeaways
15.6.2. Middle East & Africa Core Molecular Laboratory Market by Product
15.6.3. Middle East & Africa Core Molecular Laboratory Market by Technology
15.6.4. Middle East & Africa Core Molecular Laboratory Market by Application
15.6.5. Middle East & Africa Core Molecular Laboratory Market by Country
15.6.5.1. GCC
15.6.5.2. South Africa
15.6.5.3. Turkey
15.6.5.4. Rest of the Middle East & Africa
16. Competitive Landscape
16.1. Competition Dashboard
16.1.1. Global and Regional Market Share Analysis
16.1.2. Market Structure
16.2. Competitive Benchmarking
16.3. Key Strategy Analysis
16.4. Company Profiles
16.4.1.1. Company Overview
16.4.1.2. Product/Service Offerings
16.4.1.3. Financials
16.4.1.4. Recent Developments
16.4.2. Abbott Laboratories
16.4.2.1. Company Overview
16.4.2.2. Product/Service Offerings
16.4.2.3. Financials
16.4.2.4. Recent Developments
16.4.3. Hologic, Inc.
16.4.3.1. Company Overview
16.4.3.2. Product/Service Offerings
16.4.3.3. Key Financials
16.4.3.4. Recent Developments
16.4.4. Danaher Corporation
16.4.4.1. Company Overview
16.4.4.2. Product/Service Offerings
16.4.4.3. Key Financials
16.4.4.4. Recent Developments
16.4.5. Illumina, Inc.
16.4.5.1. Company Overview
16.4.5.2. Product/Service Offerings
16.4.5.3. Financials
16.4.5.4. Recent Developments
16.4.6. BioMérieux S.A.
16.4.6.1. Company Overview
16.4.6.2. Product/Service Offerings
16.4.6.3. Financials
16.4.6.4. Recent Developments
16.4.7. QIAGEN N.V.
16.4.7.1. Company Overview
16.4.7.2. Product/Service Offerings
16.4.7.3. Financials
16.4.7.4. Recent Developments
16.4.8. Thermo Fisher Scientific Inc.
16.4.8.1. Company Overview
16.4.8.2. Product/Service Offerings
16.4.8.3. Financials
16.4.8.4. Recent Developments
16.4.9. Siemens Healthineers AG
16.4.9.1. Company Overview
16.4.9.2. Product/Service Offerings
16.4.9.3. Financials
16.4.9.4. Recent Developments
16.4.10. Seegene, Inc.
16.4.10.1. Company Overview
16.4.10.2. Product/Service Offerings
16.4.10.3. Financials
16.4.10.4. Recent Developments
A comprehensive list of Core Molecular Laboratory brands/manufacturers by country will be provided along with geographical reach, employee count, revenue, product capacities, and their capabilities.
17. Disclaimer
Every Sample Includes
Research Methodology
Complete Table of Contents, List of Charts and Tables
Exclusive Facts & Illustrations
Related products
Healthcare & Pharmaceutical
COVID-19 Oral Medicine Market: Investment & Growth Opportunity Analysis, 2019-2028
Increasing R&D efforts by the public and private stakeholders are driving the market growth
Healthcare & Pharmaceutical
Global Diabetic Dietary Supplements Market Analysis and Forecast 2019-2028
The increasing prevalence of diabetes is augmenting the demand for diabetes dietary supplements
Healthcare & Pharmaceutical
Global Clinical Diagnostics Market Analysis and Forecast 2019-2028
The increasing healthcare spending and technological advancements are expected to drive the market revenue
Healthcare & Pharmaceutical
Global mRNA Technology Market: Investment & Growth Opportunity Analysis, 2020-2030
Increasing investments and R&D activities in mRNA-based technologies are fueling the market growth
Healthcare & Pharmaceutical
Global Veterinary Eye Care Therapeutics Market Analysis and Forecast, 2023-2030
The global veterinary eye care therapeutics market is estimated at US$ 780-800 million in 2022 and is expected to grow at a significant CAGR of 3.7% over the forecast period of 2022-2030.
Healthcare & Pharmaceutical
Global Laser Cosmetic Surgery Market Analysis and Forecast 2019-2028
Increasing demand for non-invasive or minimally invasive procedures drives the demand for laser cosmetic surgery